Maryland Claimed Unallowable Federal Reimbursement for Some Medicaid Physician-Administered Drugs.

摘要

For a covered outpatient drug to be eligible for Federal reimbursement under the Medicaid programs drug rebate requirements, manufacturers must pay rebates to the States. States bill the manufacturers for the rebates to reduce the cost of the drugs to the program. However, recent Office of Inspector General reviews found that States did not always bill and collect all rebates due for drugs administered by physicians in an office or hospital outpatient facility. Our objective was to determine whether Marylands Department of Health and Mental Hygiene (State agency) complied with Federal Medicaid requirements for billing manufacturers for rebates for physician-administered drugs.